Frisco, United States
Ayass BioScience, LLC is a pioneering biotechnology startup founded in 2014 with a mission to revolutionize precision patient care through the implementation of Molecular Modern Medicine. The company emphasizes pathophysiology, genetic, epigenetic, and proteomic/metabolic profiling through comprehensive immunologic testing and next-generation sequencing. The innovative research in Aptamers has allowed Ayass BioScience to develop ground-breaking technology in diagnostics and therapeutics.
The company's F420 program focuses on Transcriptome AI Analysis, which has led to a new era of genomic insights, scientific discovery, and innovation. Through single-cell resolution, long-read sequencing, and dynamic expression profiling, Ayass BioScience aims to empower the healthcare industry with the tools needed to unravel the mysteries of gene expression and revolutionize the understanding of various health conditions.
Ayass BioScience, LLC operates in the biotechnology and healthcare industries and is committed to helping clinicians implement unique precision medicine in their daily practice. With a strong emphasis on scientific innovation and a team of brilliant scientists, the company is poised to make significant contributions to the field of precision medicine.
